Journal
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 21, Issue 2, Pages 59-67Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2009.11.007
Keywords
-
Categories
Funding
- Merck Company
- USPHS [DK030834]
Ask authors/readers for more resources
GLP-1 (9-36)amide is the cleavage product of GLP-1 (7-36) amide, formed by the action of diaminopeptidyl peptidase-4 (Dpp4), and is the major circulating form in plasma. Whereas GLP-1(7-36)amide stimulates glucose-dependent insulin secretion, GLP-1(9-36)amide has only weak partial insulinotropic agonist activities on the GLP-1 receptor, but suppresses hepatic glucose production, exerts antioxidant cardioprotective actions and reduces oxidative stress in vasculature tissues. These insulin-like activities suggest a role for GLP-1 (936)amide in the modulation of mitochondrial functions by mechanisms independent of the GLP-1 receptor. In this paper, we discuss the current literature suggesting that GLP-1(9-36)amide is an active peptide with important insulin-like actions. These findings have implications in nutrient assimilation, energy homeostasis, obesity, and the use of Dpp4 inhibitors for the treatment of diabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available